Corporate Existence; Major Transaction. (A) The Company has failed to (1) place the Successor Major Transaction Consideration into escrow and instruct the escrow agent to release the Successor Major Transaction Consideration to the Holder pursuant to Section 5(b)(iii), or (2) obtain the written agreement of the Successor Entity and cause the Successor Entity to make payment as described in Section 5(b)(iii), (B) the Successor Major Transaction Consideration is not paid contemporaneously with the consummation of the Successor Major Transaction, or (C) with respect to a Major Transaction that is to be treated as an Assumption under the terms hereof, the Company has failed to meet the Assumption requirements of Section 5(b)(i); or
Appears in 3 contracts
Samples: Facility Agreement (Endologix Inc /De/), Facility Agreement (Endologix Inc /De/), Warrant Agreement (Endologix Inc /De/)
Corporate Existence; Major Transaction. (A) The Company has failed to (1x) either satisfy the requirements of Section 5(c)(iv)(a) above or place the Successor Major Transaction Consideration Warrant Early Termination Price or the Cashless Major Shares, as the case may be, into escrow and or (y) if an escrow account is required to be established pursuant to Section 5(c)(iv), to instruct the escrow agent to release such amount or such shares, as the Successor Major Transaction Consideration case may be, to the Holder pursuant to Section 5(b)(iii5(c)(iv), or (2) obtain the written agreement of the Successor Entity and cause the Successor Entity to make payment as described in Section 5(b)(iii), (B) the Successor Major Transaction Consideration is not paid contemporaneously with the consummation of the Successor Major Transaction, or (C) with respect to a Major Transaction that is to be treated as an Assumption under the terms hereof, the Company has failed to meet the Assumption requirements of Section 5(b)(i5(c)(ii); or.
Appears in 3 contracts
Samples: Warrant Agreement (Arena Pharmaceuticals Inc), Warrant Agreement (Arena Pharmaceuticals Inc), Warrant Agreement (Arena Pharmaceuticals Inc)